Biotech Values

[ghmm]

I don't get it (some) people think there have never been competing drugs on the market that didn't result in a price war. I can think of quite a few and one of them actually (though not identical) was similar and also in hepatitis C. It could easily be argued that there was more of a reason to compete on price because of a small differentiation in products (for those too young Pegasys and Peg-Intron coincidentally SGP/MRK paid a meaningful royalty to Enzon the supplier of the PEG technology for the later).